normal lung pooled sample
GLC1DM; GLC1HSR; GLC2; GLC3; NCI-H2171; GLC26; GLC28; H1963; H510A; HCC33; H2141; H1184; GLC8; GLC14; BEAS-2B; HeLa
-
proliferation (promotes); cell cycle (promotes); apoptosis (inhibits); Hippo/YAP (promotes); other pathway/process (other)
RNase R Treatment; RT-qPCR; Northern Blot; Transfection; Flow Cytometry(Non-apoptosis/cycle); Annexin V/PI Flow Cytometry; Western Blot; Bioinformatics Analysis
Potential biomarker for MYC-driven SCLC and noninvasive liquid biopsy-based approaches, based on detection in extracellular vesicles secreted by SCLC cell lines.
This study reports that circPVT1 is overexpressed in SCLC cell lines, especially MYC-amplified contexts. Functional overexpression experiments indicate that circPVT1 promotes proliferation, inhibits apoptosis, increases MYC/BCL2/YAP1, decreases POU2F3, and may contribute to SCLC tumorigenesis and subtype definition. circPVT1 is also detected in extracellular vesicles from SCLC cell lines, supporting potential biomarker relevance.
0.593
circPVT1 and PVT1/AKT3 show a role in cell proliferation, apoptosis, and tumor subtype-definition in small cell lung cancer.
combined biological and bioinformatics study